Xiaojing Wei - Peking Union Medical College Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 24 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P-254 Synergistic Induction of Senescence-Driven Immune Responses and Myeloma Cell Cytotoxicity by CDK4/6 Inhibitors and Daratumumab Combination Therapy

Shiyi Xie, Zhen Yu,Shuhui Deng,Xiaojing Wei, Chun Gan,Mu Hao,Lugui Qiu,Nikhil Munshi,Mariateresa Fulciniti,Yan Xu

Clinical Lymphoma Myeloma and Leukemia (2024): S184

引用0浏览0引用

Multiple Myeloma-Derived Mir-27B-3p Facilitates Tumor Progression Via Promoting Tumor Cell Proliferation and Immunosuppressive Microenvironment

Xiaojing Wei,Zhen Yu,Peixia Tang,Hao Sun,Lixin Gong,Lanting Liu,Teng Fang,Yi He,Tingyu Wang,Weiwei Sui,Yan Xu,Gang An,Zhenshu Xu,Xiaoke Ma,Lugui Qiu,Mu Hao

Clinical and translational medicine（2023）

引用1浏览0WOS引用

Single-cell Profiles Reveal Tumor Cell Heterogeneity and Immunosuppressive Microenvironment in Waldenström Macroglobulinemia

Sun Hao,Fang Teng,Wang Tingyu, Yu Zhen,Gong Lixin,Wei Xiaojing,Wang Huijun, He Yi,Liu Lanting,Yan Yuting,Sui Weiwei, Xu Yan,Yi Shuhua,Qiu Lugui,Hao Mu

Journal of translational medicineno. 1 (2022): 576-576

引用3浏览0WOS引用

P-096: MiR-27b-3p Suppresses CD28 Expression in T Cells and Facilitates Immune Escape of Multiple Myeloma

Zhen Yu,Xiaojing Wei,Hao Sun,Lanting Liu,Lixin Gong,Teng Fang, Yi He,Weiwei Sui,Yan Xu, Gang An,Lugui Qiu,Mu Hao

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022): S88-S88

引用0浏览0引用

Aberrant Metabolic Processes Promote the Immunosuppressive Microenvironment in Multiple Myeloma

Junqiang Lv,Hao Sun,Lixin Gong,Xiaojing Wei,Yi He,Zhen Yu,Lanting Liu,Shuhua Yi,Weiwei Sui,Yan Xu,Shuhui Deng,Gang An,Zhi Yao,Lugui Qiu,Mu Hao

Frontiers in immunology（2022）

引用5浏览0WOS引用

P-095: Exosomal Mir-27B-3p Suppresses CD28 Expression in T Cells and Facilitates Immune Escape of Multiple Myeloma

Xiaojing Wei, Zhen Yu,Hao Sun,Lanting Liu,Lixin Gong,Teng Fang,Yi He,Weiwei Sui, Gang An,Lugui Qiu,Mu Hao

Clinical Lymphoma Myeloma & Leukemia (2022): S87-S88

引用0浏览0引用

Diagnostic and Prognostic Value of Serum Mir-19A-3p in Patients with Multiple Myeloma

X J Wei,L T Liu,H Sun,L G Qiu,M Hao

PubMed（2022）

引用0浏览0WOS引用

OAB-032: Identification of Myeloma-Initiating Cells and Novel Therapeutic Target by Single-Cell Sequencing

Lixin Gong,Hao Sun,Xiaojing Wei,Lanting Liu, Zhen Yu,Yi He, Gang An,Dehui Zou,Lugui Qiu,Mu Hao

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia (2022): S19-S19

引用0浏览0引用

P-089: Disordered metabolism mediates the immunosuppressive microenvironment in multiple myeloma

Junqiang Lv,Lixin Gong,Hao Sun,Xiaojing Wei,Yi He, Zhen Yu,Lanting Liu,Weiwei Sui,Yan Xu,Shuhui Deng,Zhi Yao,Tao Cheng,Lugui Qiu,Mu Hao

Clinical Lymphoma Myeloma and Leukemia (2022): S84-S84

引用0浏览0引用

Indirubin-3’-monoxime Acts As Proteasome Inhibitor: Therapeutic Application in Multiple Myeloma

Zhen Yu,Xiaojing Wei,Lanting Liu, Hao Sun,Teng Fang, Lu Wang, Ying Li,Weiwei Sui, Keifei Wang, Yi He,Yaozhong Zhao,Wenyang Huang,Gang An,Fancui Meng,Changjiang Huang,Tengteng Yu, Kenneth Anderson,Tao Cheng,Lugui Qiu,Mu Hao

EBioMedicine (2022): 103950-103950

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn